8.22
price down icon0.36%   -0.03
after-market After Hours: 8.73 0.51 +6.20%
loading
Zynex Inc stock is traded at $8.22, with a volume of 106.19K. It is down -0.36% in the last 24 hours and down -0.48% over the past month. Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
See More
Previous Close:
$8.25
Open:
$8.23
24h Volume:
106.19K
Relative Volume:
1.16
Market Cap:
$261.77M
Revenue:
$193.67M
Net Income/Loss:
$4.82M
P/E Ratio:
17.87
EPS:
0.46
Net Cash Flow:
$15.53M
1W Performance:
-2.72%
1M Performance:
-0.48%
6M Performance:
-8.67%
1Y Performance:
-22.74%
1-Day Range:
Value
$8.02
$8.32
1-Week Range:
Value
$8.02
$8.72
52-Week Range:
Value
$7.15
$13.77

Zynex Inc Stock (ZYXI) Company Profile

Name
Name
Zynex Inc
Name
Phone
(800)-495-6670
Name
Address
9655 MAROON CIRCLE, ENGLEWOOD, CO
Name
Employee
1,101
Name
Twitter
@zynexmedical
Name
Next Earnings Date
2024-10-24
Name
Latest SEC Filings
Name
ZYXI's Discussions on Twitter

Compare ZYXI with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
9.30 0 0 0 0 0.00
 icon
GOODO
Gladstone Commercial Corporation
20.76 372.90M 0 0 0 0.00
 icon
PSNYW
Polestar Automotive Holding Uk
0.145 306.00M 2.07B -1.42B -1.37B -0.6765
 icon
MOBBW
Mobilicom Limited Warrants
0.54 278.60M 0 0 0 0.00
 icon
SHMD
Schmid Group N V
3.33 143.40M 0 0 0 0.00
 icon
JUNE
Dhandho Junoon Etf
3.89 50.60M 0 0 0 0.00

Zynex Inc Stock (ZYXI) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-16-23 Initiated RBC Capital Mkts Outperform
Jan-06-23 Upgrade Piper Sandler Neutral → Overweight
Feb-28-22 Reiterated B. Riley Securities Buy
Jul-16-21 Upgrade B. Riley Securities Neutral → Buy
Mar-09-21 Upgrade Northland Capital Market Perform → Outperform
Feb-26-21 Downgrade B. Riley Securities Buy → Neutral
Jan-29-21 Downgrade Piper Sandler Overweight → Neutral
Jan-28-21 Downgrade Northland Capital Outperform → Market Perform
Sep-14-20 Upgrade H.C. Wainwright Neutral → Buy
Sep-09-20 Upgrade Northland Capital Market Perform → Outperform
Jul-29-20 Upgrade B. Riley FBR Neutral → Buy
Jul-20-20 Initiated Piper Sandler Overweight
Jul-13-20 Downgrade B. Riley FBR Buy → Neutral
Jul-10-20 Reiterated H.C. Wainwright Neutral
Jun-16-20 Downgrade Northland Capital Outperform → Market Perform
May-19-20 Downgrade H.C. Wainwright Buy → Neutral
Apr-01-20 Initiated Northland Capital Outperform
Sep-23-19 Initiated H.C. Wainwright Buy
View All

Zynex Inc Stock (ZYXI) Latest News

pulisher
Dec 19, 2024

Electrotherapy System Market Future Business Opportunities - openPR

Dec 19, 2024
pulisher
Dec 18, 2024

How to Take Advantage of moves in (ZYXI) - Stock Traders Daily

Dec 18, 2024
pulisher
Dec 18, 2024

Zynex partners with VA to expand pain management access By Investing.com - Investing.com Canada

Dec 18, 2024
pulisher
Dec 17, 2024

Zynex partners with VA to expand pain management access - Investing.com

Dec 17, 2024
pulisher
Dec 17, 2024

Zynex's SWOT analysis: pain management firm's stock faces growth hurdles By Investing.com - Investing.com Canada

Dec 17, 2024
pulisher
Dec 17, 2024

Zynex's SWOT analysis: pain management firm's stock faces growth hurdles - Investing.com

Dec 17, 2024
pulisher
Dec 17, 2024

Zynex partners with VA to offer pain management solutions for veterans - Proactive Investors

Dec 17, 2024
pulisher
Dec 17, 2024

Zynex Announces Partnership To Conduct Business with Veterans Affairs (VA) Medical Centers, the Largest Healthcare Network in the United States (PR Newswire) - Aktiellt

Dec 17, 2024
pulisher
Dec 17, 2024

Zynex partners with Veterans Affairs Medical Centers to deliver noninvasive pain relief solutions - Proactive financial news

Dec 17, 2024
pulisher
Dec 16, 2024

Zynex, Inc. Sets Second Quarter 2023 Earnings Call - GuruFocus.com

Dec 16, 2024
pulisher
Dec 14, 2024

Zynex CEO outlines plans for 2025 after revenue milestone – ICYMI - Proactive Investors Australia

Dec 14, 2024
pulisher
Dec 13, 2024

Zynex Announces Completion of Its Laser Pulse Oximetry Trial - The Eastern Progress Online

Dec 13, 2024
pulisher
Dec 12, 2024

Zynex UCSF Study Results Demonstrate Laser Technology Benefits in Resolving Racial Bias of Current LED Pulse Oximeters - The Malaysian Reserve

Dec 12, 2024
pulisher
Dec 12, 2024

Zynex to Present at the HC Wainwright Global Investment Conference - The Eastern Progress Online

Dec 12, 2024
pulisher
Dec 12, 2024

Zynex UCSF Study Results Demonstrate Laser Technology Benefits i - GuruFocus.com

Dec 12, 2024
pulisher
Dec 12, 2024

Zynex study highlights precision of laser-based pulse oximeter in reducing racial bias - Proactive Investors UK

Dec 12, 2024
pulisher
Dec 12, 2024

ZYXI Stock Gains on the Completion of NiCO's Clinical Verification Trial - MSN

Dec 12, 2024
pulisher
Dec 11, 2024

Zynex Inc. (ZYXI) Tops Q3 Earnings Estimates - MSN

Dec 11, 2024
pulisher
Dec 10, 2024

Zynex Sets Third Quarter 2024 Earnings Call - Longview News-Journal

Dec 10, 2024
pulisher
Dec 09, 2024

Zynex Inc. Achieves $200M Milestone and Sets Ambitious Goals for 2025 - Proactive Investors UK

Dec 09, 2024
pulisher
Dec 09, 2024

Non Invasive Pain Management Devices Market Overall Study - openPR

Dec 09, 2024
pulisher
Dec 07, 2024

Objective long/short (ZYXI) Report - Stock Traders Daily

Dec 07, 2024
pulisher
Dec 07, 2024

Zynex's (ZYXI) Buy Rating Reaffirmed at HC Wainwright - MarketBeat

Dec 07, 2024
pulisher
Dec 06, 2024

CHIEF FINANCIAL OFFICER Moorhead Daniel J was granted 5,000 shares and covered exercise/tax liability with 4,879 shares, decreasing direct ownership by 42% to 35,561 units (SEC Form 4) - Quantisnow

Dec 06, 2024
pulisher
Dec 06, 2024

Zynex stock retains buy rating on FDA progress - Investing.com

Dec 06, 2024
pulisher
Dec 06, 2024

Zynex stock retains buy rating on FDA progress By Investing.com - Investing.com Canada

Dec 06, 2024
pulisher
Dec 06, 2024

Zynex completes clinical verification trial of pulse oximeter - Yahoo Finance

Dec 06, 2024
pulisher
Dec 06, 2024

Muscle Stimulator Market Next Big Thing | Major Giants- Axiobionics, Zynex, NeuroMetrix - openPR

Dec 06, 2024
pulisher
Dec 06, 2024

Hotchkis & Wiley Capital Management LLC Raises Holdings in Zynex, Inc. (NASDAQ:ZYXI) - MarketBeat

Dec 06, 2024
pulisher
Dec 06, 2024

Zynex completes trial for new pulse oximeter technology By Investing.com - Investing.com Canada

Dec 06, 2024
pulisher
Dec 05, 2024

Laser-Based Pulse Oximeter Advances Toward FDA Submission - Sleep Review

Dec 05, 2024
pulisher
Dec 05, 2024

Zynex eyes FDA submission for NiCO pulse oximeter following successful verification trial - Proactive Investors Australia

Dec 05, 2024
pulisher
Dec 05, 2024

Zynex completes trial for new pulse oximeter technology - Investing.com

Dec 05, 2024
pulisher
Dec 04, 2024

Zynex Announces Open Oximetry Project Membership - GuruFocus.com

Dec 04, 2024
pulisher
Dec 03, 2024

Zynex CFO Daniel Moorhead sells $80,800 in company stock By Investing.com - Investing.com Nigeria

Dec 03, 2024
pulisher
Dec 03, 2024

Insider Sell Alert: Daniel Moorhead Sells 10,000 Shares of Zynex Inc (ZYXI) - GuruFocus.com

Dec 03, 2024
pulisher
Dec 03, 2024

Zynex CFO Daniel Moorhead sells $80,800 in company stock - Investing.com

Dec 03, 2024

Zynex Inc Stock (ZYXI) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$2.22
price up icon 1.37%
medical_distribution YI
$0.7401
price down icon 15.90%
medical_distribution AHG
$1.25
price up icon 1.63%
medical_distribution OMI
$12.56
price up icon 0.32%
$30.86
price up icon 0.00%
Cap:     |  Volume (24h):